160 related articles for article (PubMed ID: 35814249)
1. Yu-Ping-Feng Formula Ameliorates Alveolar-Capillary Barrier Injury Induced by Exhausted-Exercise
Wang D; Li Q; Pan CS; Yan L; Sun K; Wang XY; Anwaier G; Liao QZ; Xie TT; Fan JY; Huo XM; Wang Y; Han JY
Front Pharmacol; 2022; 13():891802. PubMed ID: 35814249
[No Abstract] [Full Text] [Related]
2. Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor Cells.
Wang Y; Sun N; Luo Y; Fang Z; Fang Y; Tian J; Yu Y; Wu J; Li Y
Evid Based Complement Alternat Med; 2021; 2021():6624461. PubMed ID: 33986819
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis.
Wang JJ; Li J; Shi L; Lv XW; Cheng WM; Chen YY
J Pharm Pharmacol; 2010 Jul; 62(7):935-42. PubMed ID: 20636883
[TBL] [Abstract][Full Text] [Related]
4. Analysis of immunostimulatory activity of polysaccharide extracted from Yu-Ping-Feng in vitro and in vivo.
Fan W; Zheng P; Wang Y; Hao P; Liu J; Zhao X
Biomed Pharmacother; 2017 Sep; 93():146-155. PubMed ID: 28628831
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic evaluation of the major component astragaloside IV on the immunomodulatory effects of Yu-ping-feng prescription.
Song J; Li J; Jin Y; Wang H; Zheng S; Gao J
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):103-10. PubMed ID: 24346849
[TBL] [Abstract][Full Text] [Related]
6. The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4
Wang L; Wu W; Zhu X; Ng W; Gong C; Yao C; Ni Z; Yan X; Fang C; Zhu S
Front Pharmacol; 2019; 10():1333. PubMed ID: 31780946
[No Abstract] [Full Text] [Related]
7. Anticolitis activity of Chinese herbal formula yupingfeng powder via regulating colonic enterochromaffin cells and serotonin.
Zang KH; Rao Z; Zhang GQ; Qin HY
Indian J Pharmacol; 2015; 47(6):632-7. PubMed ID: 26729955
[TBL] [Abstract][Full Text] [Related]
8. NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula.
Luo Y; Wu J; Zhu X; Gong C; Yao C; Ni Z; Wang L; Ni L; Li Y; Zhu S
Mediators Inflamm; 2016; 2016():3541283. PubMed ID: 27034590
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulating effects of fractioned polysaccharides isolated from Yu-Ping-Feng-Powder in cyclophosphamide-treated mice.
Chen XT; Li J; Wang HL; Cheng WM; Zhang L; Ge JF
Am J Chin Med; 2006; 34(4):631-41. PubMed ID: 16883634
[TBL] [Abstract][Full Text] [Related]
10. Ulinastatin Ameliorates Pulmonary Capillary Endothelial Permeability Induced by Sepsis Through Protection of Tight Junctions via Inhibition of TNF-α and Related Pathways.
Fang M; Zhong WH; Song WL; Deng YY; Yang DM; Xiong B; Zeng HK; Wang HD
Front Pharmacol; 2018; 9():823. PubMed ID: 30150933
[No Abstract] [Full Text] [Related]
11. Effects of Yu-Ping-Feng polysaccharides on animal growth performance and immune function: a review.
Chu H; Zong Y; Yang H; Chen S; Ma Z; Li H
Front Vet Sci; 2023; 10():1260208. PubMed ID: 37799408
[No Abstract] [Full Text] [Related]
12. Anti-inflammatory and immunoregulatory effects of Yupingfeng powder on chronic bronchitis rats.
Song J; Li J; Zheng SR; Jin Y; Huang Y
Chin J Integr Med; 2013 May; 19(5):353-9. PubMed ID: 23504545
[TBL] [Abstract][Full Text] [Related]
13. PLCε1 mediates one-lung ventilation injury by regulating the p38/RhoA/NFκB activation loop.
Xin-Guo ; Yong-Yang ; Ma JQ; Xi-Zou ; Li LS; Li YH; Hu YZ; Rui-Liu
Mol Immunol; 2021 May; 133():135-145. PubMed ID: 33662817
[TBL] [Abstract][Full Text] [Related]
14. Pravastatin attenuates sepsis-induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of Cav-1/eNOS pathway.
Ren Y; Li L; Wang MM; Cao LP; Sun ZR; Yang ZZ; Zhang W; Zhang P; Nie SN
Int Immunopharmacol; 2021 Nov; 100():108077. PubMed ID: 34464887
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood-brain barrier injury through the Wnt/β-catenin signalling pathway.
Chen XY; Wan SF; Yao NN; Lin ZJ; Mao YG; Yu XH; Wang YZ
Mil Med Res; 2021 Dec; 8(1):62. PubMed ID: 34857032
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane prevents lipopolysaccharide-induced barrier dysfunction in human lung microvascular endothelial cells: Rho-mediated alterations of VE-cadherin.
Huang Y; Tan Q; Chen R; Cao B; Li W
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):119-24. PubMed ID: 26529544
[TBL] [Abstract][Full Text] [Related]
17. Continuous blood purification ameliorates endothelial hyperpermeability in SAP patients with MODS by regulating tight junction proteins via ROCK.
Yang M; Chen XM; Du XG; Cao FF; Vijaya Luxmi S; Shen Q
Int J Artif Organs; 2013 Oct; 36(10):700-9. PubMed ID: 23918271
[TBL] [Abstract][Full Text] [Related]
18. Activation of SIRT1 ameliorates LPS-induced lung injury in mice via decreasing endothelial tight junction permeability.
Fu C; Hao S; Xu X; Zhou J; Liu Z; Lu H; Wang L; Jin W; Li S
Acta Pharmacol Sin; 2019 May; 40(5):630-641. PubMed ID: 30022154
[TBL] [Abstract][Full Text] [Related]
19. Emodin enhances alveolar epithelial barrier function in rats with experimental acute pancreatitis.
Xia XM; Wang FY; Wang ZK; Wan HJ; Xu WA; Lu H
World J Gastroenterol; 2010 Jun; 16(24):2994-3001. PubMed ID: 20572302
[TBL] [Abstract][Full Text] [Related]
20. Guanine nucleotide exchange factor-H1 signaling is involved in lipopolysaccharide-induced endothelial barrier dysfunction.
Zhou Z; Guo F; Dou Y; Tang J; Huan J
Surgery; 2013 Sep; 154(3):621-31. PubMed ID: 23859306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
